Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationNote: All Grants Are U.S. Funded Through 2018
SIOPe DIPG/DMG Registry – $779,018
$779,018.00 USD
March 2022
Renewal of the European DIPG/DMG Registry
Funding of PBTCF 2022 - $25,000
$25,000.00 USD
January 2022
Massachusetts General Hospital – $50,000
$50,000.00 USD
November 2021
Targeted Protein Degradation for DIPG Therapy
CONNECT2007 - $345,794
$345,794.00 USD
September 2021
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE
CONNECT2109A - $705,764
$705,764.00 USD
September 2021
CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)
CONNECT Consortium - $278,619
$278,619.00 USD
September 2021
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors
Institute of Cancer Research – $113,747
$113,747.00 USD
September 2021
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG
Institute of Cancer Research – $498,716
$498,716.00 USD
September 2021
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical
Sydney Children’s Hospital – $195,327 USD / $265,645 AUD (Approx)
$195,327.00 USD
September 2021
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG
Children’s Hospital of Colorado – $200,000
$200,000.00 USD
September 2021
Multimodality, Combination Treatment Strategy for DIPG/DMG
Children's Cancer Institute – $50,000 USD / $68,000 AUD (Approx)
$50,000.00 USD
September 2021
Developing Novel Combination Therapies for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital – $200,000
$200,000.00 USD
September 2021
Targeting Purine Synthesis and One Carbon Metabolism in DIPG
UPMC Children's Hospital – $50,000
$50,000.00 USD
September 2021
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance
University of Queensland Diamantina Institute – $100,000 USD / $136,000 AUD (Approx)
$100,000.00 USD
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Duke University Hospital – $50,000
$50,000.00 USD
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors